Long-term safety of risankizumab from 17 clinical trials in patients with moderate-to-severe plaque psoriasis*

K. B. Gordon, M. Lebwohl, K. A. Papp, H. Bachelez, J. J. Wu, R. G. Langley, A. Blauvelt, B. Kaplan, M. Shah, Y. Zhao, R. Sinvhal, K. Reich

科研成果: 期刊稿件 › 文章 › 同行评审

63 引用 （Scopus）

指纹

探究 'Long-term safety of risankizumab from 17 clinical trials in patients with moderate-to-severe plaque psoriasis*' 的科研主题。它们共同构成独一无二的指纹。

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science